Basic Information
| RNALocate ID: | RLID-D:11001281 |
| RNA Symbol: | hsa-miR-519d-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-519d-3p |
| RNA ID: | miRBase:MIMAT0002853 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003076 | Exosome | Serum | 18589210 |
| RLID:11003077 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID-D:11000492 | Microvesicle | Fibroblasts |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-519d-3p | Oral squamous cell carcinoma | MNDR-E-MI-57826 |
| MNDR | hsa-miR-519d-3p | Large cell neuroendocrine cancer | MNDR-E-MI-57827 |
| MNDR | hsa-miR-519d-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-57828 |
| MNDR | hsa-miR-519d-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-57829 |
| MNDR | hsa-miR-519d-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-57830 |
| MNDR | hsa-miR-519d-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-57831 |
| MNDR | hsa-miR-519d-3p | Her2-receptor positive breast cancer | MNDR-E-MI-57832 |
| MNDR | hsa-miR-519d-3p | Prostate cancer | MNDR-E-MI-57833 |
| MNDR | hsa-miR-519d-3p | Gastric cancer | MNDR-E-MI-57834 |
| MNDR | hsa-miR-519d-3p | Pre-eclampsia | MNDR-E-MI-57835 |
| MNDR | hsa-miR-519d-3p | Alzheimer disease | MNDR-E-MI-57836 |
| MNDR | hsa-miR-519d-3p | Primary biliary cirrhosis | MNDR-E-MI-57837 |
| MNDR | hsa-miR-519d-3p | Lung cancer | MNDR-E-MI-57838 |
| MNDR | hsa-miR-519d-3p | Parkinson disease | MNDR-E-MI-57839 |
| MNDR | hsa-miR-519d-3p | Breast cancer | MNDR-E-MI-57840 |
| MNDR | hsa-miR-519d-3p | Pituitary neoplasms | MNDR-E-MI-57841 |
| MNDR | hsa-miR-519d-3p | Pancreatic cancer | MNDR-E-MI-57842 |
| MNDR | hsa-miR-519d-3p | Nephroblastoma | MNDR-E-MI-57843 |
| MNDR | hsa-miR-519d-3p | Colon cancer | MNDR-E-MI-57844 |
| MNDR | hsa-miR-519d-3p | Acromegaly | MNDR-E-MI-57845 |
| MNDR | hsa-miR-519d-3p | Glioblastoma | MNDR-E-MI-57846 |
| MNDR | hsa-miR-519d-3p | Glioma | MNDR-E-MI-57847 |
| MNDR | hsa-miR-519d-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-57848 |
| MNDR | hsa-miR-519d-3p | Epilepsy temporal lobe | MNDR-E-MI-57849 |
| MNDR | hsa-miR-519d-3p | Osteosarcoma | MNDR-E-MI-57850 |
| MNDR | hsa-miR-519d-3p | Pituitary adenoma | MNDR-E-MI-57851 |
| MNDR | hsa-miR-519d-3p | Non-small cell lung adenocarcinoma | MNDR-E-MI-57852 |
| MNDR | hsa-miR-519d-3p | Lung adenocarcinoma | MNDR-E-MI-57853 |
| MNDR | hsa-miR-519d-3p | Cervical cancer | MNDR-E-MI-57854 |
| MNDR | hsa-miR-519d-3p | Cholangiocarcinoma | MNDR-E-MI-57855 |
| MNDR | hsa-miR-519d-3p | Synovial sarcoma | MNDR-E-MI-57856 |
| MNDR | hsa-miR-519d-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-57857 |
| MNDR | hsa-miR-519d-3p | Hepatocellular carcinoma | MNDR-E-MI-57858 |
| MNDR | hsa-miR-519d-3p | Embryonal cancer | MNDR-E-MI-57859 |
| MNDR | hsa-miR-519d-3p | Barrett's adenocarcinoma | MNDR-E-MI-57860 |
| MNDR | hsa-miR-519d-3p | Tonsil cancer | MNDR-E-MI-57861 |
| MNDR | hsa-miR-519d-3p | Colorectal cancer | MNDR-E-MI-57862 |
| MNDR | hsa-miR-519d-3p | Nasopharynx carcinoma | MNDR-E-MI-57863 |
| MNDR | hsa-miR-519d-3p | Fetal growth retardation | MNDR-E-MI-57864 |
| MNDR | hsa-miR-519d-3p | Nasopharyngeal cancer | MNDR-E-MI-57865 |
| MNDR | hsa-miR-519d-3p | Stroke lacunar | MNDR-E-MI-57866 |
| MNDR | hsa-miR-519d-3p | Barrett's carcinogenesis | MNDR-E-MI-57867 |
| MNDR | hsa-miR-519d-3p | Breast cancer her3+ negative | MNDR-E-MI-57868 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AKT3 | Homo sapiens | RR00067473 |
TOP